Patent Assignment
Reel/Frame 072881/0226
Assignment of Assignor's Interest
Recorded: 2025-11-12
Pages: 3
Assignee
SPECTRUM PHARMACEUTICALS, INC.
100 S. SAUNDERS ROAD, SUITE 300, LAKE FOREST, ILLINOIS, 60045
Covered Properties
(2)
Methods of Treating Chemotherapy Induced Neutropenia Using Fixed Doses of Eflapegrastim
Methods of Treating Chemotherapy Induced Neutropenia Using Fixed Doses of G-Csf Protein Complex
Application:
18/946,005 →
Publication:
US 2025/0121032
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest
Sep 22, 2022
From: SPECTRUM PHARMACEUTICALS, INC.; ALLOS THERAPEUTICS, INC.; TALON THERAPEUTICS, INC.
To: SLR INVESTMENT CORP., AS COLLATERAL AGENT
Reel/Frame 061179/0202 →
Termination and Release of Intellectual Property Security Agreement Recorded at Reel 061179/Frame 0202
Aug 1, 2023
From: SLR INVESTMENT CORP.
To: SPECTRUM PHARMACEUTICALS, INC.; ALLOS THERAPEUTICS, INC.; TALON THERAPEUTICS, INC.
Reel/Frame 064463/0709 →
Assignment of Assignor's Interest
May 1, 2026
From: SPECTRUM PHARMACEUTICALS, INC.
To: ASSERTIO SPECIALTY PHARMACEUTICALS, LLC
Reel/Frame 074542/0184 →